I CAN understand America’s reluctance to have NHS-style medical care in part.

In America, those with thyroid inactivity problems, which thyroxine does not solve alone, are given the chance to have an additional hormone T3 in combination with thyroxine.

The results are encouraging.

We in the UK are not given the chance of this treatment.

It’s not the cost, it’s not availability – it’s dogma.

GLYN LIMMER, Roosevelt Road, Long Hanborough